Page 61 - TD-2-1
P. 61

Tumor Discovery                                                       LCP2 regulates melanoma progression



            cytokines and chemokines to activate CD8 T lymphocytes,   References
                                             +
            which finally suppressed the growth of melanoma.
                                                               1.   Torre LA, Bray F, Siegel RL,  et al., 2015, Global cancer
            5. Conclusions                                        statistics, 2012. CA Cancer J Clin, 65(2): 87–108.
                                                                  https://doi.org/10.3322/caac.21262
            LCP2 is a novel prognostic biomarker of melanoma, which
            could positively regulate the IRF5 signaling pathway to   2.   Schadendorf D, Fisher DE, Garbe C, et al., 2015, Melanoma.
            activate tumor-infiltrating CD8  T-cells and then inhibit   Nat Rev Dis Primers, 1: 15003.
                                     +
            the growth of melanoma. Nevertheless, it is important to      https://doi.org/10.1038/nrdp.2015.3
            point out that there are some limitations in our study. First,   3.   Luke JJ, Flaherty KT, Ribas A, et al., 2017, Targeted agents
            the potential association between LCP2 and IRF5 is unclear,   and immunotherapies: Optimizing outcomes in melanoma.
            which needs to be systematically and deeply explored   Nat Rev Clin Oncol, 14(8): 463.
            in vitro and in vivo. Second, more public data on melanoma      https://doi.org/10.1038/nrclinonc.2017.43
            patients who received immunotherapy should be included   4.   Redman JM, Gibney GT, Atkins MB, 2016, Advances in
            for  bioinformatics  analysis  in  this  study  to  investigate   immunotherapy for melanoma. BMC Med, 14(1): 20.
            prognostic significance of LCP2 in these patients.
                                                                  https://doi.org/10.1186/s12916-016-0571-0
            Acknowledgments                                    5.   D’Arcangelo D, Giampietri C, Muscio M, et al., 2018, WIPI1,

            None.                                                 BAG1, and PEX3 autophagy-related genes are relevant
                                                                  melanoma markers. Oxidat Med Cell Longev, 2018: 1471682.
            Funding                                               https://doi.org/10.1155/2018/1471682

            This study was supported by grants from General Program,   6.   Gerami P, Cook RW, Wilkinson J, et al., 2015, Development
            the National Natural Science Foundation of China      of a prognostic genetic signature to predict the metastatic
            (No. 81874138, 82073020 and 81903222).                risk associated with cutaneous melanoma. Clin Cancer Res,
                                                                  21(1): 175–183.
            Conflict of interest                                  https://doi.org/10.1158/1078-0432.CCR-13-3316

            The authors declare no conflicts of interest.      7.   Zhao Y, Schaafsma E, Gorlov IP,  et al., 2018, A leukocyte
                                                                  infiltration score defined by a gene signature predicts
            Author contributions                                  melanoma patient prognosis. Mol Cancer Res, 17(1): 109filtra.

            Conceptualization: Mingzhu Yin                        https://doi.org/10.1158/1541-7786.MCR-18-0173
            Data curation: Hongyin Sun, Kui Deng               8.   Clements JL, Ross-Barta SE, Tygrett LT, et al., 1998, SLP-76
            Investigation: Hongyin Sun, Kui Deng                  expression is restricted to hemopoietic cells of monocyte,
            Validation: Xingchen Zhou, Dongsheng Cao, Yan Cheng   granulocyte, and T lymphocyte lineage and is regulated
            Writing – original draft: Hongyin Sun, Kui Deng, Mingzhu   during T cell maturation and activation.  J  Immunol,
               Yin                                                161: 3880–3889.
            Writing – review & editing: Xiang Chen, Mingzhu Yin  9.   Jumaa H, Wollscheid B, Mitterer M, et al., 1999, Abnormal
                                                                  development and function of B lymphocytes in mice
            Ethics approval and consent to participate            deficient for the signalling adaptor protein SLP-65.
                                                                  Immunity, 11: 547–554.
            All  the  procedures  of  animal  study  were evaluated  and
            approved  by  the  Institutional  Animal  Care  and  Use      https://doi.org/10.1016/s1074-7613(00)80130-2
            Committee of Xiangya Hospital, Central South University   10.  Zhang J, Wang L, Xu X, et al., 2020, Transcriptome-based
            (No. 2022020685).                                     network analysis unveils eight immune-related genes as
                                                                  molecular signatures in the immunomodulatory subtype of
            Consent for publication                               triple negative breast cancer. Front Oncol, 10: 1787.
                                                                  https://doi.org/10.3389/fonc.2020.01787
            Not applicable.
                                                               11.  Huo Y, Zhang K, Han S,  et al., 2021, Lymphocyte
            Availability of data                                  cytosolic protein 2 is a novel prognostic marker in lung
                                                                  adenocarcinoma. J Int Med Res, 49(11): 3000605211059681.
            The data used to support the findings of this study are
            available from the corresponding author on reasonable      https://doi.org/10.1177/03000605211059681
            request.                                           12.  Wang Z, Peng M, 2021, A novel prognostic biomarker LCP2


            Volume 2 Issue 1 (2023)                         11                          https://doi.org/10.36922/td.308
   56   57   58   59   60   61   62   63   64   65   66